RxDoctor Payments Data

Sahas Narain

Cornea and External Diseases Specialist · Rockville Ctr, NYNPI 1346773041

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,983 of the $6,258 with a category attached, or 63.6%. 17 manufacturers reported payments, led by Alcon at 43.3% of the total. 2025 is the largest year on record at $3,911, more than ten times the $127 reported in 2021. Among cornea and external diseases specialist clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,258in general payments, 2019–2025

Across 137 payments — averaging $45.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$3K
  • Bausch & Lomb Americas Inc.$1K
  • Tarsus Pharmaceuticals, Inc.$729
  • Sun Pharmaceutical Industries Inc.$444
  • Rxsight Inc$179
  • Dompe US, Inc.$162
  • plus $657 from 11 others

What the payments were for

  • Speaking & faculty fees$2,27536%
  • Food & beverage$3,98364%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,258 in reported general payments places this provider in the 90th percentile of 26 cornea and external diseases specialist providers in New York.

See all cornea and external diseases specialist providers in New York

Medicare billing

Part B allowed, 2024
$99,286
Medicare patients
292
Services billed
666

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate86$2,508
Loteprednol Etabonate13$2,408
MoxifloxacinMoxifloxacin Hcl68$1,515
Latanoprost21$293
Ofloxacin15$213
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha14$175

Paid to pharmacies, not to this prescriber.

Other cornea and external diseases specialist in Rockville Ctr

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →